JMDC Inc
TSE:4483
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
JMDC Inc
Free Cash Flow
JMDC Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
JMDC Inc
TSE:4483
|
Free Cash Flow
¥7.1B
|
CAGR 3-Years
54%
|
CAGR 5-Years
220%
|
CAGR 10-Years
N/A
|
|
|
M3 Inc
TSE:2413
|
Free Cash Flow
¥53.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
19%
|
|
|
S
|
Software Service Inc
TSE:3733
|
Free Cash Flow
¥2.8B
|
CAGR 3-Years
50%
|
CAGR 5-Years
17%
|
CAGR 10-Years
35%
|
|
|
Medley Inc
TSE:4480
|
Free Cash Flow
¥3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CareNet Inc
TSE:2150
|
Free Cash Flow
¥2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
31%
|
CAGR 10-Years
21%
|
|
|
Medical Data Vision Co Ltd
TSE:3902
|
Free Cash Flow
¥719.8m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
JMDC Inc
Glance View
Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.
See Also
What is JMDC Inc's Free Cash Flow?
Free Cash Flow
7.1B
JPY
Based on the financial report for Dec 31, 2025, JMDC Inc's Free Cash Flow amounts to 7.1B JPY.
What is JMDC Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
220%
Over the last year, the Free Cash Flow growth was 12%. The average annual Free Cash Flow growth rates for JMDC Inc have been 54% over the past three years , 220% over the past five years .